Saudi Press

Saudi Arabia and the world
Thursday, Dec 04, 2025

‘Ground zero of the opioid epidemic’: West Virginia puts drug giants on trial

‘Ground zero of the opioid epidemic’: West Virginia puts drug giants on trial

A series of federal cases over the pharmaceutical industry’s push to sell narcotic painkillers which created the worst drug epidemic in US history
The trial of the three biggest US drug distributors for illegally flooding West Virginia with hundreds of millions of prescription opioid pills, and driving the highest overdose rate in the country, is due to open on Monday.

The city of Huntington and surrounding Cabell county are suing McKesson, AmerisourceBergen and Cardinal Health, among the largest corporations in the US, as part of a series of federal cases over the pharmaceutical industry’s push to sell narcotic painkillers which created the worst drug epidemic in American history.

The two West Virginia local authorities accuse the distributors of turning Cabell county, with a population of just 90,000, into the “ground zero of the opioid epidemic sweeping the nation”, by flooding the area with nearly 100m opioid pills over a decade.

The lawsuit claims the companies put profit before lives by working in concert with “pill mill” doctors and pharmacists who were little better than drug dealers in supplying opioids to anyone who paid, in breach of laws requiring distributors to halt and report suspicious sales.

“The wholesale distributors have wholly ignored their legal obligations,” lawyers for Cabell county said.

“Instead of implementing controls to stop opioid abuse and alerting authorities to suspicious orders, the distributors have chosen to abuse their privileged position, lining their pockets by shipping massive quantities of drugs to distributors, pharmacies, and dispensaries without performing any checks – with devastating consequences to Americans.”

The companies say they were doing no more than delivering legal drugs to licensed pharmacies to fill prescriptions written by doctors.

If the trial goes ahead on Monday, it will be the first in a series of bellwether cases to establish whether opioid makers, distributors and pharmacy chains are liable to pay out billions of dollars to thousands of counties, cities and Native American tribes harmed by an epidemic that has caused more than 500,000 deaths since 1999 and blighted the lives of millions more.

In October 2019, McKesson and AmerisourceBergen were among four companies that agreed to pay $260m to settle another case hours before a trial was to begin in Ohio, threatening to expose what the distributors knew about illegal sales of the opioids they were delivering to fill prescriptions written by doctors and dispensed by pharmacists who have since been imprisoned.

In the West Virginia case, the distributors are seeking to prevent testimony by witnesses including West Virginia’s former chief health officer, Dr Rahul Gupta.

Defence lawyers want to block Gupta speaking about whether the pharmaceutical industry’s push to sell opioids led to overdose deaths, and whether addiction to prescription opioids drew people into using illegal narcotics such heroin and fentanyl which are not the main cause of overdoses.

The companies also do not want Gupta to speak about the epidemic’s impact on social issues such as the number of children taken into foster care.

Opioid distributors have paid out hundreds of millions of dollars to settle federal accusations that they failed to meet legal obligations to halt suspicious opioid deliveries, including McKesson which paid a record $150m fine in 2017.

Joseph Rannazzisi, a former senior Drug Enforcement Administration official who took action against the distributors, has called them “criminals” and said they “lack a conscience”.

The West Virginia lawsuit accuses the distributors of creating a “public nuisance”, a claim successfully used by Oklahoma against Johnson & Johnson over its push to sell opioids in the state using false claims about effectiveness and safety. A judge awarded the state $465m.

Drug distributors delivered 1.1bn opioid pills to West Virginia between 2006 and 2014, even as the state’s overdose rate rose to the highest in the US. Nearly 9m pills went to a single pharmacy in the small town of Kermit, with a population of 350, over just two years.

In 2018, the heads of the three drug distributors were lambasted at a congressional hearing by both Democrats and Republicans after denying their companies played any part in the opioid epidemic.

David McKinley, a Republican representing a West Virginia district, accused the CEOs of feeding the epidemic by riding roughshod over the law.

“None of you was complying with state law,” he said. “And yet you say, ‘We weren’t responsible.’ I think you were very much responsible.”

McKinley asked why, if doctors and pharmacists have gone to prison, drug distributor executives should not be jailed too.

“I just want you to feel shame about your roles, respectively, in all of this,” he said.
Newsletter

Related Articles

Saudi Press
0:00
0:00
Close
As Trump Deepens Ties with Saudi Arabia, Push for Israel Normalization Takes a Back Seat
Thai Food Village Debuts at Saudi Feast Food Festival 2025 Under Thai Commerce Minister Suphajee’s Lead
Saudi Arabia Sharpens Its Strategic Vision as Economic Transformation Enters New Phase
Saudi Arabia Projects $44 Billion Budget Shortfall in 2026 as Economy Rebalances
OPEC+ Unveils New Capacity-Based System to Anchor Future Oil Output Levels
Will Saudi Arabia End Up Bankrolling Israel’s Post-Ceasefire Order in Lebanon?
Saudi Arabia’s SAMAI Initiative Surpasses One-Million-Citizen Milestone in National AI Upskilling Drive
Saudi Arabia’s Specialty Coffee Market Set to Surge as Demand Soars and New Exhibition Drops in December
Saudi Arabia Moves to Open Two New Alcohol Stores for Foreigners Under Vision 2030 Reform
Saudi Arabia’s AI Ambitions Gain Momentum — but Water, Talent and Infrastructure Pose Major Hurdles
Tensions Surface in Trump-MBS Talks as Saudi Pushes Back on Israel Normalisation
Saudi Arabia Signals Major Maritime Crack-Down on Houthi Routes in Red Sea
Italy and Saudi Arabia Seal Over 20 Strategic Deals at Business Forum in Riyadh
COP30 Ends Without Fossil Fuel Phase-Out as US, Saudi Arabia and Russia Align in Obstruction Role
Saudi-Portuguese Economic Horizons Expand Through Strategic Business Council
DHL Commits $150 Million for Landmark Logistics Hub in Saudi Arabia
Saudi Aramco Weighs Disposals Amid $10 Billion-Plus Asset Sales Discussion
Trump Hosts Saudi Crown Prince for Major Defence and Investment Agreements
Families Accuse OpenAI of Enabling ‘AI-Driven Delusions’ After Multiple Suicides
Riyadh Metro Records Over One Hundred Million Journeys as Saudi Capital Accelerates Transit Era
Trump’s Grand Saudi Welcome Highlights U.S.–Riyadh Pivot as Israel Watches Warily
U.S. Set to Sell F-35 Jets to Saudi Arabia in Major Strategic Shift
Saudi Arabia Doubles Down on U.S. Partnership in Strategic Move
Saudi Arabia Charts Tech and Nuclear Leap Under Crown Prince’s U.S. Visit
Trump Elevates Saudi Arabia to Major Non-NATO Ally Amid Defense Deal
Trump Elevates Saudi Arabia to Major Non-NATO Ally as MBS Visit Yields Deepened Ties
Iran Appeals to Saudi Arabia to Mediate Restart of U.S. Nuclear Talks
Musk, Barra and Ford Join Trump in Lavish White House Dinner for Saudi Crown Prince
Lawmaker Seeks Declassification of ‘Shocking’ 2019 Call Between Trump and Saudi Crown Prince
US and Saudi Arabia Forge Strategic Defence Pact Featuring F-35 Sale and $1 Trillion Investment Pledge
Saudi Sovereign Wealth Fund Emerges as Key Contender in Warner Bros. Discovery Sale
Trump Secures Sweeping U.S.–Saudi Agreements on Jets, Technology and Massive Investment
Detroit CEOs Join White House Dinner as U.S.–Saudi Auto Deal Accelerates
Netanyahu Secures U.S. Assurance That Israel’s Qualitative Military Edge Will Remain Despite Saudi F-35 Deal
Ronaldo Joins Trump and Saudi Crown Prince’s Gala Amid U.S.–Gulf Tech and Investment Surge
U.S.–Saudi Investment Forum Sees U.S. Corporate Titans and Saudi Royalty Forge Billion-Dollar Ties
Elon Musk’s xAI to Deploy 500-Megawatt Saudi Data Centre with State-backed Partner HUMAIN
U.S. Clears Export of Advanced AI Chips to Saudi Arabia and UAE Amid Strategic Tech Partnership
xAI Selects Saudi Data-Centre as First Customer of Nvidia-Backed Humain Project
A Decade of Innovation Stagnation at Apple: The Cook Era Critique
President Trump Hosts Saudi Crown Prince Mohammed bin Salman in Washington Amid Strategic Deal Talks
Saudi Crown Prince to Press Trump for Direct U.S. Role in Ending Sudan War
Trump Hosts Saudi Crown Prince: Five Key Takeaways from the White House Meeting
Trump Firmly Defends Saudi Crown Prince Over Khashoggi Murder Amid Washington Visit
Trump Backs Saudi Crown Prince Over Khashoggi Killing Amid White House Visit
Trump Publicly Defends Saudi Crown Prince Over Khashoggi Killing During Washington Visit
President Donald Trump Hosts Saudi Crown Prince Mohammed bin Salman at White House to Seal Major Defence and Investment Deals
Saudi Arabia’s Solar Surge Signals Unlikely Shift in Global Oil Powerhouse
Saudi Crown Prince Receives Letter from Iranian President Ahead of U.S. Visit
Saudi Arabia’s Crown Prince Begins Washington Visit to Cement Long-Term U.S. Alliance
×